News

January 21, 2022

The deadline for the 2021 EuroTEST assessment of the impact of Covid 19 on testing services for HIV, HBV, HCV, STIs in the WHO European Region has been extended to 13 March. 

 

The survey aims to understand the continued impact of the Covid 19 pandemic on testing services for HIV, viral hepatitis and STIs in the WHO European Region. If you provide testing for one of these infections at the laboratory, clinical or community level, please consider responding to the survey.

 

Access the survey here: https://redcap.link/COVID-19_impact_2021


More info: https://www.eurotest.org/Projects-Collaborations/COVID-19-impact-assessment-on-testing

 

The survey is available in English and Russian.

January 15, 2022

WSPID 2022

22 – 24 February 2022

 

The 12th World Congress of the World Society for Paediatric Infectious Diseases (WSPID) will be held online from 22-24 February 2022 to address the most important issues in infectious diseases that affect children and their families. WSPID, the only global society that is devoted entirely to paediatric diseases in children, invites you to hear the latest developments relevant to your patients, to interact with world experts in all aspects of paediatric infectious diseases, to meet colleagues from all over the world and to network for new opportunities and collaborations to address the immense burden of infectious diseases.

Learn more at https://wspid2022.com/

January 14, 2022

EACS at ECCMID 2022

23-26 April 2022

 

EACS will co-organise a session at the 32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), taking place in Lisbon, Portugal from 23-26 April 2022.

Updates on HIV treatment and prevention

- Progress toward reaching HIV prevention and treatment targets in Europe

- HIV treatment: which are the drugs?

- HIV and the cure: what is new in the HIV vaccine research?

- Patients’ perspectives on PrEP

More information

January 13, 2022

In memoriam of David Stuart

EACS is saddened about the sudden passing of David Stuart. He was a prominent much respected and loved activist in the UK; but his reach was across Europe and globally. He will be greatly missed. Our thoughts are with his family, friends and colleagues.

December 1, 2021

World AIDS Day 2021 Message from the President and President-elect

Dear EACS Members

It has been forty years since the first cases of AIDS were described in the USA. We lost many good people, but we have come a long way since then; efficient testing and prevention, effective, well-tolerated, easy-to-use and widely available anti-retroviral therapy and prevention. However, things have not been as straightforward. The last two years have been dominated by another pandemic; COVID-19. Many of us have lost friends, family, loved-ones and colleagues to yet another dreadful viral infection. Not only has this set us back from achieving our targets for ending AIDS as a major threat but has also highlighted many of the inequalities that exist in health and social care globally, regionally and nationally.

Now, more than ever is the time to tackle inequalities and get the global response to both these pandemics on track. It is time to apply lessons learned.


As the recent UNAIDS 2021 report; “Confronting Inequalities: Lessons for pandemic responses from 40 years of AIDS” shows that, in 2020, we had 680 000 AIDS-related deaths and 1.5 million new infections. There were 37.7 million people living with HIV, of who 10.2 million were not on treatment. There are inequalities at many levels; testing and prevention services, ART provision, harm-reduction services, criminalisation and the failure to address the needs of key populations. Moreover, lack of joined-up physical and wholistic psycho-social care for people living with HIV and stigma are widespread.


Despite the hardships of COVID-19, our mission at EACS remains steadfast. We will continue to work with our members, clinical and academic organisations, community organisations, governments, NGOs and the pharmaceutical industry to advance knowledge, promote and develop good practice, value advances in scientific technologies and above all, dispel stigma and challenge inequalities.

The UK AIDS Memorial Quilt which was displayed at the recent European AIDS Conference in London, reminds us of the need to always remember and cherish the ones that we have lost and remember the lessons for our future.

As 2021 draws to a close, and we commemorate World AIDS Day, let’s cross boundaries and work together to end inequalities.

We need each other. No one forgotten, none left behind. This concerns us all.


Please remain active members of our EACS Society and stay safe.


Sanjay Bhagani, President, EACS
Esteban Martinez, President-elect, EACS

 

November 23, 2021

The Mayo Clinic/University of Liverpool Virtual Conference on Clinical Pharmacology of Antiretrovirals and Antimycobacterials

1-2 December 2021

 

The Mayo Clinic/University of Liverpool Virtual Conference on Clinical Pharmacology of Antiretrovirals and Antimycobacterials is a two half-day event on 1st - 2nd December 2021, between 3:00 – 6:00 PM GMT, designed for healthcare professionals faced with prescribing antiretroviral and antimycobacterial treatment in increasingly complex patients. 

The virtual conference, with free registration, seeks to improve patient treatment outcomes through educating attendees on emerging topics in antiretroviral and antimycobacterial clinical management, especially in relation to clinical pharmacology (pharmacokinetics and pharmacodynamics), management of drug-drug interactions (DDIs) and complex patient cases.

For further details and registration, click here.

November 16, 2021

EACS LIVE! Interactive case-based discussion

22 November 2021

120 mins (18:00-20:00 Japan time, 10:00-12:00 CET)

 

Opening address: Sanjay Bhagani, EACS President, United Kingdom

Chairs :

EACS

  • Jürgen Rockstroh, Germany
  • Tristan Barber, United Kingdom

Japanese Society for AIDS Research

  • Toshibumi Taniguchi, Japan
  • Takashi Muramatsu
  • Hideta Nakamura

Case-based discussions

Case 1: Management of long-term ART and co-morbidities

Presenter: Ryuui Miyashita, Japan

Case 2: Management of unsuppressed viremia/resistance

Presenter: Yasuaki Yanagawa, Japan

Case 3: COVID-19 and HIV

Presenter: Maria Mazzitelli, Italy

Read more

November 3, 2021

NCHIV21 conference

23 November 2021

 

NCHIV serves as platform for stakeholders in the Netherlands to share and discuss the latest insights and developments in research concerning the pathogenesis, epidemiology, prevention and treatment of HIV.

NCHIV is intended for a wide audience, including biomedical scientists in HIV/AIDS, HIV treating physicians, pharmacologists, infectious disease epidemiologists, (medical) microbiologists and HIV nurses.

More information on the programme

11 / 45

20th European AIDS Conference

15-18 October 2025 Paris, France

EACS Guidelines updated

The EACS 12.0 and the app are available for free on

Apple Store and Google Play Store

Read more

Educational Programme

Training and educating the next generation of clinicians and researchers is an EACS core activity.

Read more

EACS Resource Library

Access all scientific content of EACS core activities! (members only)

Read more

New Interim Guidance

Interim Guidance on the Use of Statin Therapy for the Primary Prevention of Cardiovascular Disease in People with HIV

Read more